BioCentury
ARTICLE | Clinical News

PolyHeme hemoglobin polymer: After FDA clearance, has increased the dosage in the ongoing Phase II trial to the equivalent of six units of blood, or 300 grams,

March 13, 1995 8:00 AM UTC

Northfield Laboratories Inc. (NFLD), Evanston, Ill. Product: PolyHeme hemoglobin polymer Indication: Blood loss Status: After FDA clearance, has increased the dosage in the ongoing Phase II trial to t...